Literature DB >> 21150521

The role of rotation thromboelastometry in early prediction of massive transfusion.

Harald Leemann1, Thomas Lustenberger, Peep Talving, Leslie Kobayashi, Marko Bukur, Mirko Brenni, Martin Brüesch, Donat R Spahn, Marius J B Keel.   

Abstract

INTRODUCTION: Early prediction of massive transfusion (MT) is critical in the management of severely injured trauma patients. Variables available early after injury including physiologic, laboratory, and rotation thromboelastometric (ROTEM) parameters were evaluated as predictors for the need of MT.
METHODS: After Institutional Review Board approval, we retrospectively reviewed a cohort of severely injured trauma patients (Injury Severity Score ≥ 16) admitted to a Level I trauma center with available ROTEM measurements on hospital admission during a 1-year study period. Patients with isolated head injury (Abbreviated Injury Scale head ≥ 3 and Abbreviated Injury Scale chest, abdomen, and extremity < 3) and patients with a penetrating mechanism of injury were excluded. Patients who received a MT (≥ 10 units packed red blood cell within 24 hours of admission) were compared with patients who did not. Variables independently associated with MT were identified using stepwise logistic regression.
RESULTS: A total of 53 patients met inclusion criteria. Of these, 18 patients (34.0%) received a MT and 35 patients (66.0%) did not. Massively transfused patients had significantly lower baseline hemoglobin values (7.9 g/dL ± 0.4 g/dL vs. 11.4 g/dL ± 0.4 g/dL; p < 0.001) and a trend toward higher lactate (4.8 mmol/L ± 0.8 mmol/L vs. 3.0 mmol/L ± 0.3 mmol/L; p = 0.056) and base deficit values (5.9 mmol/L ± 1.1 mmol/L vs. 3.6 mmol/L ± 0.6 mmol/L; p = 0.052). Mean international normalized ratio (1.46 ± 0.07 vs. 1.22 ± 0.05; p = 0.001) and partial thromboplastin times (42.4 seconds ± 5.0 seconds vs. 29.7 seconds ± 1.8 seconds; p < 0.001) were significantly higher in MT patients. Patients receiving a MT had significantly altered ROTEM values on admission compared with non-MT patients. An increase in the clot formation time (471.3 seconds ± 169.9 seconds vs. 178.1 seconds ± 19.9 seconds; p = 0.001), a shortening of the maximum clot firmness (37.5 mm ± 2.9 mm vs. 50.7 mm ± 1.4 mm; p < 0.001), and a shortening of the clot amplitude at all time points (10/20/30 minutes) were observed in massively transfused trauma patients. Variables independently associated with MT included a hemoglobin level ≤ 10 g/dL and an abnormal maximum clot firmness value (area under the receiver operator characteristic curve: 0.831 [95% confidence interval: 0.719-0.942; p < 0.001]).
CONCLUSION: Hemoglobin ≤ 10 g/dL and an abnormal maximum cloth firmness measured by rotation thromboelastometry on admission reliably predict the need for MT. Prospective validation of the effectiveness of thromboelastometry to guide the transfusion practice after trauma is warranted.

Entities:  

Mesh:

Year:  2010        PMID: 21150521     DOI: 10.1097/TA.0b013e3181faaa25

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  29 in total

Review 1.  Coagulopathy after severe pediatric trauma.

Authors:  Sarah C Christiaans; Amy L Duhachek-Stapelman; Robert T Russell; Steven J Lisco; Jeffrey D Kerby; Jean-François Pittet
Journal:  Shock       Date:  2014-06       Impact factor: 3.454

2.  External validation of a smartphone app model to predict the need for massive transfusion using five different definitions.

Authors:  E I Hodgman; M W Cripps; M J Mina; E M Bulger; M A Schreiber; K J Brasel; M J Cohen; P Muskat; J G Myers; L H Alarcon; M H Rahbar; J B Holcomb; B A Cotton; E E Fox; D J Del Junco; C E Wade; H A Phelan
Journal:  J Trauma Acute Care Surg       Date:  2018-02       Impact factor: 3.313

3.  Evolving concepts and strategies in the management of polytrauma patients.

Authors:  Gaurav K Upadhyaya; Karthikeyan P Iyengar; Vijay Kumar Jain; Rakesh Garg
Journal:  J Clin Orthop Trauma       Date:  2020-10-13

4.  A simple predictive formula for the blood requirement in patients with high-energy blunt injuries transferred within one hour post-trauma.

Authors:  Yukio Akasaki; Hiroshi Sugimori; Kenta Momii; Tomohiko Akahoshi; Suguru Matsuura; Yukihide Iwamoto; Yoshihiko Maehara; Makoto Hashizume
Journal:  Acute Med Surg       Date:  2014-10-20

5.  Hypercoagulability After Resection of Thoracic Malignancy: A Prospective Evaluation.

Authors:  Michelle B Mulder; Kenneth G Proctor; Evan J Valle; Alan S Livingstone; Dao M Nguyen; Robert M Van Haren
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

6.  Thromboelastography values from pigtail macaques ( Macaca nemestrina): effects of age and sex.

Authors:  Derek L Fong; James C Ha; Charlotte E Hotchkiss
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-01       Impact factor: 1.232

Review 7.  Viscoelastic testing inside and beyond the operating room.

Authors:  Liang Shen; Sheida Tabaie; Natalia Ivascu
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

Review 8.  Management of bleeding and coagulopathy following major trauma: an updated European guideline.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

9.  Resuscitation and monitoring in gastrointestinal bleeding.

Authors:  Yusuf Alper Kılıç; Ali Konan; Volkan Kaynaroğlu
Journal:  Eur J Trauma Emerg Surg       Date:  2011-05-17       Impact factor: 3.693

10.  The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition.

Authors:  Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund A M Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Donat R Spahn
Journal:  Crit Care       Date:  2016-04-12       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.